Glaxosmithkline Pharma standalone net profit declines 23.13% in the June 2016 quarter

Sales rise 7.99% to Rs 685.21 crore

Net profit of Glaxosmithkline Pharma declined 23.13% to Rs 72.27 crore in the quarter ended June 2016 as against Rs 94.01 crore during the previous quarter ended June 2015. Sales rose 7.99% to Rs 685.21 crore in the quarter ended June 2016 as against Rs 634.49 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales685.21634.49 8 OPM %13.1917.51 -PBDT114.37151.01 -24 PBT109.00146.09 -25 NP72.2794.01 -23

Powered by Capital Market - Live News